Skip to content

Efficacy and safety evaluation of traditional Chinese medicine combined with quadruple therapy in the treatment of helicobacter pylori infection-related diseases: a retrospective study

Efficacy and safety evaluation of traditional Chinese medicine combined with quadruple therapy in the treatment of helicobacter pylori infection-related diseases: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2100004805
Enrollment
Unknown
Registered
2021-05-04
Start date
2021-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

helicobacter pylori infection-related diseases

Interventions

Sponsors

Jiangxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Aged 14 to 70 years, no gender limit; 2.Meet the diagnostic criteria for Hp infection (by urea breath test, serum antibody, stool antigen, gastroscopy or biopsy).

Exclusion criteria

Exclusion criteria: 1. Patients with cardiovascular and cerebrovascular diseases such as coronary atherosclerotic heart disease, stroke, Alzheimer's disease, Parkinson's disease, etc.; 2. Those with incomplete medical history, medication history and related examination records; 3. Anti-Hp treatment medication course of treatment <7 days; 4. Those who took other drugs or combined other related medical history during medication.

Design outcomes

Primary

MeasureTime frame
The recurrence rate of Helicobacter pylori;Helicobacter pylori eradication rate;

Countries

China

Contacts

Public ContactChen Xiaofang

Jiangxi University of Traditional Chinese Medicine

xiaofanci122306@163.com+86 18507915566

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026